Miguel Olivas-Aguirre

9PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsReaction engineering (excl. nuclear reactions)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 14, 2026
Pharmacological Modulation of Autophagy Can Sensitize Acute Lymphoblastic Leukemia Cell Lines to Dexamethasone.

Liliana Torres-López, Miguel Olivas-Aguirre, Alejandro Chávez-Gutiérrez

|Sep 10, 2025
Ion channels in NK cells: Signaling and functions.

Igor Pottosin, Kathya Villatoro-Gómez, Miguel Olivas-Aguirre

|Nov 09, 2024
Impact of Modern Lifestyle on Circadian Health and Its Contribution to Adipogenesis and Cancer Risk.

Oxana Dobrovinskaya, Javier Alamilla, Miguel Olivas-Aguirre

|Jan 21, 2023
Dexamethasone-Induced Fatty Acid Oxidation and Autophagy/Mitophagy Are Essential for T-ALL Glucocorticoid Resistance.

Miguel Olivas-Aguirre, Jesús Pérez-Chávez, Liliana Torres-López

|Mar 26, 2022
Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges.

Miguel Olivas-Aguirre, Liliana Torres-López, Kathya Villatoro-Gómez

Pageof 2